Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

JAK3 Staining and CD68+ Macrophage Counts Are Increased in Patients with IgA Nephropathy.

Diagnostics (Basel, Switzerland)·2026

Same author

Dengue Infection as a Trigger for Collapsing Glomerulopathy in Patients With <i>APOL1</i> High-Risk Genotype.

Kidney international reports·2025

Same author

Performance of Creatinine and Cystatin C-Based Equations to Estimate Glomerular Filtration Rate Among Patients With Heart Failure.

Circulation. Heart failure·2025

Same author

Performance of GFR estimation equations in pediatric hematology-oncology patients.

Pediatric nephrology (Berlin, Germany)·2025

Same author

Genotype-phenotype correlations and clinical outcomes of genetic TRPC6 podocytopathies.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025

Same author

Intracapillary Monoclonal IgM Deposition Concomitant With Cold Agglutinin Disease.

Kidney medicine·2025

Search research articles

Related Experiment Videos

Tuberculosis-associated collapsing glomerulopathy: remission after treatment.

Camila E Rodrigues¹, Luís H B C Sette, Juliana Torritani

¹Nephrology Division of University of São Paulo School of Medicine, São Paulo, Brazil. camila_eleuterio@yahoo.com.br

|February 2, 2010

Summary

This study details a case of collapsing glomerulopathy (CG) in an HIV-negative patient with tuberculosis. Successful treatment of tuberculosis and use of corticotherapy led to full kidney recovery after temporary dialysis.

Related Experiment Videos

Area of Science:

Nephrology
Infectious Diseases
Immunology

Background:

Collapsing glomerulopathy (CG) is a severe nephrotic syndrome often linked to HIV infection.
CG typically has a poor treatment response and frequently progresses to end-stage renal disease.
While CG can occur with other conditions, renal prognosis remains unfavorable.

Observation:

A case of an HIV-negative patient presenting with collapsing glomerulopathy was observed.
The patient had co-existing tuberculosis (TB) and required temporary dialysis for five months.
The patient's condition was managed with tuberculosis treatment and corticotherapy.

Findings:

Tuberculosis-related collapsing glomerulopathy can occur in HIV-negative individuals.
Aggressive treatment targeting the underlying infection (TB) and inflammation (corticotherapy) can lead to significant renal recovery.
Complete recovery of kidney function was achieved after a period of dialysis.

Implications:

This case highlights the importance of considering and treating underlying infections, such as tuberculosis, in patients with collapsing glomerulopathy.
It suggests that a favorable renal outcome may be achievable even in severe cases of CG with appropriate management.
The findings support exploring combined therapeutic strategies for non-HIV-associated collapsing glomerulopathy.